TCM
WINT

Tamarack Capital Management’s Windtree Therapeutics Inc WINT Stock Holding History

Tamarack Capital Management’s Portfolio WINT Stock Details WINT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q2 		– Sell
-16,824
Closed -$280K – 45
2015
Q1 		$280K Sell
16,824
-90,319
-84% -$1.78M 0.04% 39
2014
Q4 		$1.74M Hold
107,143
– – 0.26% 36
2014
Q3 		$2.76M Hold
107,143
– – 0.61% 30
2014
Q2 		$2.77M Buy
107,143
+35,714
+50% +$913K 0.57% 25
2014
Q1 		$2.15M Buy
71,429
+53,854
+306% +$1.81M 0.54% 24
2013
Q4 		$554K Buy
+17,575
New +$550K 0.13% 28

Other funds holding WINT

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BC
Broadfin Capital New York $747M AUM 100.56% 1-Year Est. Return
DCM
DAFNA Capital Management Los Angeles, California $440M AUM 109.12% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
TI
Turner Investments Berwyn, Pennsylvania $134K AUM 49.03% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Tamarack Capital Management's WINT Position: Q2 2015 in Review

Tamarack Capital Management sold out of Windtree Therapeutics Inc (WINT) in Q2 2015, closing a stake of 16,824 shares — an estimated $280K sold.

Tamarack Capital Management first reported a position in WINT in Q4 2013 and held it in 6 quarters. The position peaked at $2.77M in Q2 2014. 52 funds tracked by Wall St. Rank hold WINT as of Q2 2015.

  • Tamarack Capital Management reported no remaining Windtree Therapeutics Inc position as of Q2 2015 after selling out during the quarter.
  • Tamarack Capital Management sold 16,824 Windtree Therapeutics Inc shares in Q2 2015, an estimated $280K.
  • Tamarack Capital Management first reported a position in Windtree Therapeutics Inc in Q4 2013 and held it in 6 quarters.
  • Tamarack Capital Management's Windtree Therapeutics Inc position peaked at $2.77M in Q2 2014.
  • 52 funds tracked by Wall St. Rank held Windtree Therapeutics Inc as of Q2 2015.

Based on Tamarack Capital Management's 13F filing for Q2 2015, filed 11 Aug 2015.